- 米国企業
- Shockwave Medical, Inc.
Shockwave Medical, Inc.SWAV
時価総額
$123.5億
PER
83.8倍
2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Product revenue | 43 | 68 | 237 | 490 | 730 |
Cost of product revenue | 17 | 21 | 41 | 65 | 95 |
Gross profit | 26 | 47 | 196 | 425 | 635 |
Research and development | 33 | 37 | 51 | 82 | 146 |
Sales and marketing | 31 | 52 | 111 | 162 | 235 |
General and administrative | 14 | 24 | 35 | 57 | 95 |
Total operating expenses | 95 | 112 | 197 | 301 | 476 |
Income (loss) from operations | -52 | -66 | -1 | 124 | 159 |
Loss from equity method investment | - | - | -6 | -2 | -2 |
Interest expense | 1 | 1 | 1 | 2 | 7 |
Other income (expense), net | - | - | -1 | 1 | 24 |
Net income (loss) before taxes | -51 | -66 | -9 | 121 | 174 |
Income Tax Expense (Benefit) | 0 | 0 | 0 | -95 | 27 |
Net income (loss) | -51 | -66 | -9 | 216 | 147 |
Unrealized gain (loss) on available-for-sale securities, net of tax | - | -0 | -0 | -1 | 1 |
Adjustment for net gain realized and included in other income, net | - | 21,000 | - | 0 | 0 |
Total comprehensive income (loss) | -51 | -66 | -9 | 215 | 148 |
Basic (USD per share) | - | - | - | 6.02 | 4.01 |
Diluted (USD per share) | - | - | - | 5.7 | 3.85 |